成都史纪生物制药有限公司是集动物疫苗研发、生产、销售与技术服务为一体的国家高新技术企业。公司累计投资超过5亿元人民币，现拥有3个疫苗生产车间，8条独立的活/灭活疫苗生产线，并配套相应规模的质量控制实验室、实验动物房等设施，年产能达150亿头(羽)份。

公司拥有独特的双品牌核心竞争力“3-6-5”，即史纪生物^®3大极致工艺(ICF悬浮培养工艺、ABE纯化工艺、HR&IE剂型工艺) ，铸就6系列苛刻品质疫苗产品，慧眼实验室5项技术服务，助力猪业健康。

Chengdu SG-Biotech Co., Ltd. is a national high-tech enterprise that integrates the research and development, production, sales, and technical services of animal vaccines. The company has accumulated an investment of over 500 million RMB and currently operates three vaccine production workshops with eight independent live/inactivated vaccine production lines. These are complemented by corresponding quality control laboratories, experimental animal facilities, and other facilities, enabling an annual production capacity of 15 billion doses. The company boasts a unique dual-brand core competitive advantage known as "3-6-5," representing the three ultimate processes of  SG-Biotech^Ⓡ (ICF Suspension Culture Process, ABE Purification Process, HR&IE Formulation Process). This results in the creation of six series of high-quality vaccine products and five technical services from the Huiyan Laboratory, all contributing to the promotion of swine industry health.